Event

Journal Club - Modelling in Drug Development

Add to:

For the last event of 2012, Simon Kirby and Kayode Ogungbenro joined us to present their work on modelling in drug development.

CHAIR: Stephen Pyke, GSK

Speaker: Kayode Ogungbenro, Centre for Applied Pharmacokinetic Research, The University of Manchester
Application of optimal design methodologies in clinical pharmacology experiments
Co-authors: Aristides Dokoumetzidis and Leon Aarons;
Pharmaceutical Statistics, Volume 8, Issue 3, Pages 239–252, July/September 2009
Abstract | Paper+ | Slides 

Speaker: Simon Kirby, Pfizer
Discounting phase 2 results when planning phase 3 clinical trials
Co-authors: J. Burke, C. Chuang-Stein and C. Sin;
Pharmaceutical Statistics, Volume 11, Issue 5, Pages 373–385, September/October 2012
Abstract | Paper+ | Slides

+ Papers available to view from 29th November 2012 to 27th December 2012.

For a flier advertising the event, please click here.

 

Upcoming Events

PSI ToxSIG Webinar: Beyond the looking glass - Interpreting animal welfare & behaviour by monitoring & assessing mice activity data

Analysing continuously collected locomotive activity data to interpret mice welfare and behaviour.

PSI Journal Club: Survival Analysis

Our next journal club features two papers on the topic of Survival Analysis. For each of these published papers there will be a 20 minute presentation by author followed by a 10 minute discussion.

PSI VisSIG Webinar: Rapid Insights to Data

The field of data visualization is the intersection of data journalism, statistics, graphic design, computer science, neuroscience, and cognitive psychology. We will focus on the latter two fields of data visualization as it relates to data visualization: neuroscience and cognitive psychology.

PSI One-Day Meeting: Non-proportional hazards and applications in immuno-oncology

Hear about potential strategies to handle non-proportional hazards and delayed treatment effects from experts in the field.

Latest Jobs

Biostatistician Project Leader

As a statistician in the Biostatistics and Programming Department, you will be responsible for the methodological and statistical aspects of projects in early clinical development in order to optimize the early development plan and ensure its coherence.

Director Biostatistics

By joining our company, in this role you will apply your skills and experience in support of developing scientifically based arguments aiming to provide fair accessibility to our company’s drugs and vaccines making a real difference in patient’s lives.

Director of Statistics

As a Director of Statistics, you will be accountable for guiding statisticians in their work, performing senior review of documentation and output deliveries, providing oversight and advising on best practices approach to statistics for clinical trials.